1例大面积脑梗死患者的药物重整与药学监护

中国药物警戒 ›› 2019, Vol. 16 ›› Issue (5): 297-300.

• 安全性评价与合理用药 • 上一篇下一篇

1例大面积脑梗死患者的药物重整与药学监护

邸琨¹, 吴巧娜¹, 张亚南¹, 刘素亭¹, 刘晶磊^2,*

1 石家庄市第三医院药学部,河北石家庄 050011;
2 中国人民解放军联勤保障部队第980医院血管外科,河北石家庄 050081

收稿日期:2018-10-22 修回日期:2019-06-11 出版日期:2019-05-20 发布日期:2019-06-11
通讯作者: 刘晶磊,男,硕士,主治医师,介入治疗。E-mail：liujinglei2000@163.com
作者简介:邸琨,女,硕士,主管药师,临床药学。

Medication Reconciliation and Pharmaceutical Care for One Case of Large Hemispheric Infarction

DI Kun¹, WU Qiaona¹, ZHANG Yanan¹, LIU Suting¹, LIU Jinglei^2,*

1 Department of Pharmacy, the Third Hospital of Shijiazhuang, Hebei Shijiazhuang 050011, China;
2 980 Hospital of PLA Joint Logistics Surport Forces, Hebei Shijiazhuang 050081, China

Received:2018-10-22 Revised:2019-06-11 Online:2019-05-20 Published:2019-06-11

摘要/Abstract

摘要： 目的通过临床药师参与1例大面积脑梗死患者的治疗实践,探讨在临床治疗过程中临床药师提供以药物重整为基础的药学服务的可行性、有效性。方法临床药师对患者进行入院、出院药物重整、住院期间用药医嘱审核,发现用药问题,提出药物调整建议,与医生共同讨论决定药物治疗方案,对住院患者进行全程的药学监护。结果避免了一些可预防的药品不良事件与用药偏差的发生,经过系统治疗,患者病情好转出院。结论以药物重整为基础的药学服务可优化药物治疗方案,确保患者医疗安全,实现药物治疗的准确性、连续性。

关键词: 药物重整, 药学监护, 大面积脑梗死

Abstract: Objective To explore the feasibility and effectiveness of clinical pharmacists providing pharmaceutical care (PC) based on medication reconciliation (MR) in clinical therapy through clinical pharmacists participating in the treatment process of a patient with large hemispheric infarction (LHI). Methods The clinical pharmacists performed MR and checked prescription on patient, and then searched medication errors and provided advice on the medication therapy. In the end pharmacists discussed with the doctors to decide the medication regimens, conducted the whole-process pharmaceutical care for the hospitalized patient. Results Some preventable adverse drug events and medication errors were avoided, and the patient was discharged in good condition after systematic treatment. Conclusion Medication reconciliation-based pharmaceutical care can optimize medication regimens, ensure patients' medical safety, and achieve the accuracy and consistency of medication therapy.

Key words: medication reconciliation, pharmaceutical care, large hemispheric infarction

中图分类号:

R972.7

邸琨, 吴巧娜, 张亚南, 刘素亭, 刘晶磊. 1例大面积脑梗死患者的药物重整与药学监护[J]. 中国药物警戒, 2019, 16(5): 297-300.

DI Kun, WU Qiaona, ZHANG Yanan, LIU Suting, LIU Jinglei. Medication Reconciliation and Pharmaceutical Care for One Case of Large Hemispheric Infarction[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 297-300.

参考文献

[1] Sen S, Siemianowski L, Murphy M, et al.Implementation of a pharmacy technician-centered medication reconciliation program at an urban teaching medical center[J]. Am J Health Syst Pharm, 2014,71(1):51-56.
[2] Kilcup M, Schultz D, Carlson J, et al.Postdischarge pharmacist medication reconciliation: Impact on readmission rates and financial savings[J]. J Am Pharm Assoc, 2013, 53(1):78-84.
[3] Renaudin P, Boyer L, Esteve M A, et al.Do pharmacistled medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis[J]. Br J Clin Pharmacol,2016,82(6):1660-1673.
[4] Alex S, Adenew A B, Arundel C, et al.Medication errors despite using electronic health records: the value of a clinical pharmacist service in reducing discharge-related medication eerrors[J]. Qual Manag Health Care, 2016, 25(1):32-37.
[5] Chen C M, Kuo L N, Cheng K J, et al.The effect of medication therapy management service combined with a national PharmaCloud system for polypharmacy patients[J]. Comput Methods Programs Biomed, 2016,134:109-119.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015,48(4):246-257.
[7] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J]. 中华心血管病杂志, 2007, 35(4):295-304.
[8] Jauch E C, Saver J L, Adams H P, et al.Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals form AHA/ASA[J]. Stroke, 2013, 44(3):870-947.
[9] 黄珊, 林玮玮, 宋洪涛. 药物重整对内科慢性病患者的作用[J]. 解放军药学学报, 2017, 33(2):198-199.
[10] Whelton P K, Carey R M, Aronow W S, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation. 2018, 138(17):e426-e483.
[11] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J]. 中华神经科杂志, 2015, 48(4):258-273.
[12] 中国脑梗死急性期康复专家共识组. 中国脑梗死急性期康复专家共识[J]. 中华物理医学与康复杂志, 2016, 38(1):1-6.
[13] Pronovost P, Weast B, Schwarz M, et al.Medication reconciliation: A practical tool to reduce the risk of medication errors[J]. J Crit Care, 2003, 18(4):201-205.
[14] 刘莹,崔向丽,刘丽宏. 国内外药物重整研究进展[J]. 中国药学杂志, 2015, 50(24):2099-2102.
[15] 李娟, 张成志, 陈庆宪, 等. 17个省(区、市)56家“三甲”医院医务人员及患者对临床药师的需求及评价调查[J]. 中国药房, 2018, 29(8):1136-1139.

1例大面积脑梗死患者的药物重整与药学监护

Medication Reconciliation and Pharmaceutical Care for One Case of Large Hemispheric Infarction

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	张夏兰, 袁静, 吴斌, 秦媛媛. 甲磺酸阿帕替尼在恶性肿瘤患者的用药特征分析[J]. 中国药物警戒, 2023, 20(8): 927-932.
[2]	王然, 李轶凡, 刘小艳, 冯欣. 1例妊娠期药物暴露风险的药学监护[J]. 中国药物警戒, 2023, 20(8): 933-934.
[3]	刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.
[4]	杨岩, 周德喜, 吴欣俐, 薛淑雅, 丁海华, 张泉, 张云玲. 84例新型抗肿瘤药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(3): 334-338.
[5]	姚鑫, 葛秋格, 李亚敏, 王一帆, 李媛媛, 刘志强. 2018~2022年某院新型抗肿瘤药物消化系统不良反应分析[J]. 中国药物警戒, 2023, 20(11): 1273-1278.
[6]	郑金凤, 王景红. 1例多药联用致室性心律失常的药学监护[J]. 中国药物警戒, 2023, 20(11): 1279-1281.
[7]	苏甦, 伍诗琪, 张青霞, 闫素英. 1例吲达帕胺致粒细胞缺乏症患者的药学监护[J]. 中国药物警戒, 2023, 20(11): 1282-1285.
[8]	王燕婷, 张媛媛, 陈怡然, 孙捷, 朱宇, 杨荔艳, 吴知桂, 申丽君, 程敏, 李国辉. 1例恶性肿瘤患者抗感染与抗肿瘤治疗的平衡抉择及药学监护[J]. 中国药物警戒, 2023, 20(10): 1168-1172.
[9]	王祺茹, 左丽, 杜琼, 叶玲, 阮聪, 翟青, 徐蕊. 1例奥拉帕利致Ⅳ度骨髓抑制患者的药学监护[J]. 中国药物警戒, 2023, 20(10): 1176-1180.
[10]	孙雪林, 张攀, 胡欣. 1例维得利珠单抗治疗重症溃疡性结肠炎的药学监护[J]. 中国药物警戒, 2022, 19(7): 782-785.
[11]	唐静雅. 临床药师参与1例肠外营养相关性肝损伤治疗的药学监护[J]. 中国药物警戒, 2022, 19(7): 786-788.
[12]	李雁铭, 赵志刚. 基于循证的伊布替尼不良反应及药学监护[J]. 中国药物警戒, 2022, 19(7): 807-811.
[13]	刘蕾, 张会娟, 钱效森, 孙瑞芳. 1例磺胺脱敏方案治疗干燥综合征合并卡氏肺孢子菌肺炎的药学监护[J]. 中国药物警戒, 2022, 19(6): 680-683.
[14]	周鹏, 杨晶晶. 3种清热解毒类中药注射剂的药学监护[J]. 中国药物警戒, 2022, 19(4): 441-445.
[15]	杜婧,李永辉,阎纳新,郭立杰,刘洋. 1例哌拉西林他唑巴坦治疗肺脓肿患者致药物热及横纹肌溶解症药学监护[J]. 中国药物警戒, 2022, 19(4): 450-452.